HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Many viruses, including HIV-1, target the human leukocyte antigen (HLA) class I molecules HLA-A, HLA-B, and HLA-C to evade immune surveillance. HIV-1 Nef selectively downregulates HLA-A and HLA-B, whereas Vpu variants from primary strains reduce cell-surface HLA-C expression. Whether HIV-1 also uses Vpu to target other HLA molecules has remained unclear. Here, we show that Vpu from primary strains reduces HLA-A, including the globally prevalent HLA-A2, on infected cells. Although Nef is the principal modulator of these molecules, Vpu acts independently of Nef and impairs TCR-mediated recognition of infected cells in co-culture systems. However, the reduction in TCR signaling is also dependent on the presence of BST2/tetherin, a restriction factor that retains nascent virions and targets them for degradation. HLA-A2-restricted, HIV-specific CTL responses were lowest when both Nef and Vpu were present. Vpu variants from chronic and transmitted/founder strains, but not from the prototypical recombinant strain NL4.3, were sufficient to reduce cell-surface HLA-A2, although activity varied widely among variants and appears to have arisen independently in different hosts. Coimmunoprecipitation and immunofluorescence analyses showed that Vpu interacts with HLA-A2 and redirects it to a perinuclear compartment which is probably the trans -Golgi network through a mechanism governed by the Vpu N-terminus/transmembrane domain. Overall, our findings reveal a previously unrecognized function of Vpu and show how HIV-1 uses Nef and Vpu to limit HLA-A-mediated viral antigen presentation and promote immune evasion.
IMPORTANCE
We show that the HIV-1 accessory protein Vpu, like Nef, downmodulates HLA-A on infected cells. Because Vpu also downmodulates HLA-C, it can substantially reduce overall HLA class I abundance and, consequently, viral antigen presentation to cytotoxic T lymphocytes (CTLs). Vpu impairs TCR-mediated recognition of infected cells through two distinct mechanisms: HLA-A2 downregulation and reduced virion retention through antagonism of the restriction factor BST2. CTL responses were most diminished when both Nef and Vpu were present, supporting a role for Vpu in evading T cell-mediated immunity. The ability of Vpu proteins from primary HIV-1 strains across clades and groups but not from the prototypical recombinant strain NL4.3 to reduce HLA-A2 levels suggests that HIV-1 evolved an additional mechanism to evade immune recognition and control.
Article activity feed
-
HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms https://www.biorxiv.org/content/10.64898/2026.11.04.764327v1
-
HIV-1 Vpu complements HLA-A downregulation by Nef and impairs TCR-mediated recognition of HIV-infected cells through distinct mechanisms https://www.biorxiv.org/content/10.64898/2026.11.04.764327v1
-